Search results
Results from the WOW.Com Content Network
PepsiCo currently pays a quarterly dividend of $1.355 per share, equating to a 12-month payout of $5.42 per share and a dividend yield of 3.1%. Despite being a Dividend King, the company's stock ...
PepsiCo is an interesting stock, even if you are not focused on passive income.
Passive income investors are right to consider adding PepsiCo (NASDAQ: PEP) stock to their portfolios. *Stock prices used were the afternoon prices of Oct. 11, 2024. The video was published on Oct ...
On April 20, 2009, PepsiCo offered to buy the remaining portion of PepsiAmericas, at an offer of $23.27 – or $11.64 plus 0.223 PepsiCo shares – in exchange for each PepsiAmericas share. [1] In August 2009, PepsiCo also made an offer for Pepsi Bottling Group , the world's largest bottler of Pepsi-Cola products.
In March 2021, in order to increase the span of vaccination beyond adults, Moderna started the clinical trials of vaccines on children age 6-months to 11-years-old in the US and in Canada (KidCove), [151] in addition to the existing and fully-enrolled study on 12-17 year-olds (TeenCOVE).
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
Vaccine stocks continued to fall in premarket trading on Friday, following a sharp decline on Thursday after President-elect Donald Trump announced he would appoint Robert F. Kennedy Jr. to head ...
Vaxine began work on a COVID-19 vaccine in January 2020. After developing a vaccine adjuvant the company decided to focus on a "recombinant protein-based vaccine". A phase 1 human trial started in June 2020. The phase 1 trial involved 40 participants, 30 of whom received the vaccine. The remaining ten participants received a saline placebo. [7]